Dexmedetomidine Infusion and Postoperative Lung Aeration After Thoracic Surgery
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Jul 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the effects of a medication called dexmedetomidine on lung function after patients undergo thoracic surgery, which involves procedures on the lungs or chest area. The trial involves two groups: one group will receive dexmedetomidine while the other group will receive a placebo, which is a harmless saline solution. The goal is to see if the specific way dexmedetomidine is given can help improve lung aeration—essentially, how well the lungs can fill with air and function after surgery.
To participate in this trial, patients need to be adults aged between 18 and 80 who are scheduled for certain types of lung surgeries, like lobectomy or segmentectomy. However, if someone has urgent surgical needs, certain heart conditions, liver or kidney disease, or is not fluent in English, they may not be eligible. Participants can expect to receive either the medication or the placebo during their surgery, and the study aims to ensure that the way dexmedetomidine is administered is followed consistently. This trial is currently recruiting participants, and it aims to improve how anesthesia is given during lung surgeries to enhance recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Adult patients (Age \>18 years until 80 years) undergoing lobectomy and/or segmentectomy.
- Exclusion Criteria:
- • Urgent or emergency thoracic surgery.
- • Other concomitant non-pulmonary procedures (pleurectomy, diaphragmatic procedures, pericardiocentesis, esophageal procedures, thymectomy).
- • Prior lung resection surgery.
- • Epidural block for intraoperative or postoperative analgesia.
- • Preoperative arrhythmia (second degree AV block or pacemaker) or significant bradycardia (heart rate \< 50).
- • Preoperative hypotension (mean arterial blood pressure \< 65 mmHg).
- • Severe functional liver or kidney disease.
- • Non-English speakers
- • Consent withdrawal.
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Matthew B Allen, MD
Principal Investigator
Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported